Itapevi
Itapevi turns 242,995 residents, R$15.6 billion in GDP and a R$155 million Eurofarma lab into a low-cost attachment point on Sao Paulo's industrial bloodstream.
Itapevi does not win by escaping Sao Paulo. It wins by attaching itself to the metropolis without paying Sao Paulo's full cost. Recent IBGE-based reporting puts the municipality near 242,995 residents in 2025, and Itapevi sits roughly 772 metres above sea level on the western edge of the metropolitan region. Most summaries treat it as another commuter city beyond Barueri and Jandira. The more useful lens is that Itapevi has become a lower-cost operating surface for industries that want metro access without metro land prices.
The clearest proof sits in the pharmaceutical corridor. Eurofarma says its Eurolab complex at the Itapevi unit spans 21,170 square metres, involved an investment of R$155 million ($28 million) and supports more than 750 professionals dedicated to new products and innovation. That is not warehouse spillover. It is research infrastructure. Broader municipal reporting says Itapevi closed 2023 with GDP of R$15.6 billion ($2.9 billion), placing it among the 150 richest municipalities in Brazil, and highlights a diversified industrial park with a strong pharmaceutical tilt. Companies keep choosing the municipality because the location lets them sit on the Castello Branco axis, stay inside the Sao Paulo labor and supplier field, and still build at a scale that would be harder farther east.
That is the real Wikipedia gap. Itapevi is not simply absorbing growth from somewhere else. It is metabolizing metropolitan overflow into its own industrial identity. The city benefits from proximity to a giant host, but it also gives something back: manufacturing, research, distribution capacity and tax base that the wider region uses. In business terms, Itapevi behaves like a strategic attachment zone where being slightly outside the center is an advantage rather than a handicap.
The mechanism is commensalism reinforced by mutualism and keystone-species dynamics. Sao Paulo's scale supplies markets, roads, capital and labor. A few anchor manufacturers then turn that borrowed circulation into local employment and investment. Biologically, Itapevi resembles barnacles. Barnacles prosper by fixing themselves to a larger moving body and filtering value from the current that body creates. Itapevi does the metropolitan version on concrete and asphalt.
Eurofarma's Itapevi-based Eurolab alone spans 21,170 square metres, cost R$155 million ($28 million) to build and supports more than 750 R&D staff inside a municipality with R$15.6 billion in GDP.